5442 Federal Register / Vol. 81, No. 21 / Tuesday, February 2, 2016 / Notices 

Title: Section 87.109, Station logs. 

Form No.: N/A. 

Type of Review: Extension of a 

currently approved collection. 

Respondents: Business or other forprofit entities. 

Number of Respondents and 

Responses: 5 respondents and 5 

responses. 

Estimated Time per Response: 100 

hours. 

Frequency of Response: 

Recordkeeping requirement. 

Obligation to Respond: Required to 

obtain or retain benefits. Statutory 

authority for this collection of 

information is contained in 47 U.S.C. 

154, 303 and 307(e) unless otherwise 

noted. 

Total Annual Burden: 500 hours. 

Annual Cost Burden: No cost. 

Privacy Act Impact Assessment: No 

impact(s). 

Nature and Extent of Confidentiality: 

There is no need for confidentiality with 

this collection of information. 

Needs and Uses: Section 87.109 of the 

Commission’s rules require that a 

station at a fixed location in the 

international aeronautical mobile 

service (IAMS) must maintain a log 

(written or automatic log) in accordance 

with the Annex 10 provisions of the 

International Civil Aviation 

Organization (ICAO) Convention. This 

log is necessary to document the quality 

of service provided by fixed stations, 

including the harmful interference, 

equipment failure, and logging of 

distress and safety calls where 

applicable. This information is used by 

the Commission to ensure that 

particular stations are licensed and 

operated in compliance with applicable 

rules, statutes, and treaties. 

Federal Communications Commission. 

Gloria J. Miles, 

Federal Register Liaison Officer, Office of the 

Secretary. 

[FR Doc. 2016–01823 Filed 2–1–16; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL TRADE COMMISSION 

[Docket No. 9357] 

LabMD, Inc. Oral Argument Before the 

Commission 

AGENCY: Federal Trade Commission. 

ACTION: Oral argument; open meeting. 

SUMMARY: The Federal Trade 

Commission (‘‘FTC’’ or ‘‘Commission’’) 

will meet on Tuesday, March 8, 2016, in 

Room 532 of the FTC Building for an 

Oral Argument In the Matter of LabMD, 

Inc. The public is invited to attend and 

observe the open portion of the meeting, 

which is scheduled to begin at 1:00 p.m. 

The remainder of the meeting will be 

closed to the public. 

DATES: Oral argument is scheduled for 

March 8, 2016 at 1:00 p.m. 

ADDRESSES: Federal Trade Commission 

Building, 600 Pennsylvania Avenue 

NW., Washington, DC 20580. 

FOR FURTHER INFORMATION CONTACT: 

Donald S. Clark, Secretary, Office of the 

Secretary, 600 Pennsylvania Avenue 

NW., Washington, DC 20580, 202–326– 

2515. 

SUPPLEMENTARY INFORMATION: 

Open Meeting 

(1) Oral Argument In the Matter of 

LabMD, Inc., Docket No. 9357. 

Closed Meeting 

(2) Executive Session to follow Oral 

Argument In the Matter of LabMD, Inc., 

Docket No. 9357. 

Record of Commission’s Vote 

On January 20, 2016, Commissioners 

Ramirez, Ohlhausen, and McSweeny 

were recorded as voting in the 

affirmative to close Matter Number (2), 

and to withhold from this meeting 

notice such information as is exempt 

from disclosure under 5 U.S.C. 

552b(c)(10). Commissioner Brill was 

recorded as not participating. 

Commission’s Explanation of Closing 

The Commission has determined that 

Matter Number (2) may be closed under 

5 U.S.C. 552b(c)(10), and that the public 

interest does not require the matter to be 

open. 

General Counsel Certification 

The General Counsel has certified that 

Matter Number (2) may properly be 

closed, citing the following relevant 

provision: 5 U.S.C. 552b(c)(10). 

Expected Attendees 

Expected to attend the closed meeting 

are the Commissioners themselves, an 

advisor to one of the Commissioners, 

and such other Commission staff as may 

be appropriate. 

By direction of the Commission, 

Commissioner Brill not participating. 

Donald S. Clark, 

Secretary. 

[FR Doc. 2016–01852 Filed 2–1–16; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 81 FR 4912–4913, dated 

January 28, 2016) is amended to reflect 

the reorganization of the National 

Center on Birth Defects and 

Developmental Disabilities, Centers for 

Disease Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the title and 

function statements for the Division of 

Birth Defects and Developmental 

Disabilities (CUBB) and insert the 

following: 

Division of Congenital and 

Developmental Disorders (CUBB). (1) 

Conducts research to determine the 

causes and prevention of birth defects 

and developmental disabilities; (2) 

maintains and expands support for 

state-based surveillance; (3) evaluates 

the effectiveness of efforts to prevent 

birth defects and developmental 

disabilities; (4) conducts and 

disseminates findings of epidemiologic 

research, investigations, 

demonstrations, and programs directed 

toward the prevention of selected 

adverse reproductive outcomes that are 

environmentally related; (5) provides 

assistance to State and local health 

departments on community exposures 

to terotogenic, mutagenic, embryotoxic, 

other environmental agents, and genetic 

influences adversely interfering with 

normal growth and development; (6) 

conducts research and develops 

programs to identify women at high risk 

of an alcohol-exposed pregnancy and to 

fund epidemiologic and clinical 

research studies aimed at early 

identification and intervention of 

children affected by prenatal alcohol 

exposure; (7) works closely with 

international organizations and entities 

in developing strategies and programs 

for reducing the number of birth defects 

and developmental disabilities; (8) 

develops and evaluates prevention 

strategies and provides training, 

technical consultation, and assistance to 

States and localities in developing their 


wgreen on DSK2VPTVN1PROD with NOTICES